Valiant Laboratories Closes Trading Window from Jan 1, 2026, for Q3 FY26 Results
Valiant Laboratories Limited will close its trading window from January 1, 2026. The window will reopen 48 hours after the declaration of financial results for the quarter and nine-months ended December 31, 2025. This is in compliance with SEBI regulations.
The closure of the trading window is a standard procedure mandated by SEBI regulations before the announcement of financial results. It does not directly impact the company's operations or financial performance, hence the impact is considered low.
The announcement is a routine regulatory disclosure regarding the closure of the trading window and does not contain any specific financial performance data or strategic business updates that would indicate a positive or negative sentiment.
Valiant Laboratories Limited has announced the closure of its trading window for dealing in the company's securities. The closure will be effective from January 01, 2026, and will remain in effect until 48 hours after the declaration of the financial results for the quarter and nine-months ended December 31, 2025.
This decision is in accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal Code of Conduct for Prevention of Insider Trading. The trading window closure applies to all Directors, Promoters, Promoter Group, Designated Persons, their Immediate Relatives, and Connected Persons.
The company has also uploaded this intimation on its official website, www.valiantlabs.in. The announcement was made by Akshay Gangurde, Company Secretary & Compliance Officer.
What to do with a filing like this
Valiant Laboratories Limited filed this with the NSE as a statutory disclosure, categorised under trading window disclosure. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Valiant Laboratories Limited. Read the original for the full detail.